Events - ESTRO 2016

Philips innovations, dedicated to radiation oncology

At this year’s European Society for Radiotherapy and Oncology Forum, to be held in Turin, Italy, from 29 April to 3 May, Philips will showcase our latest innovative solutions in radiation oncology. The innovations highlighted this year increase workflow automation, confidence, consistency and accuracy in cancer treatment. They allow you to obtain quality results in less time and provide enhanced patient-centric care.

To learn more about our dedicated solutions in radiation oncology, click here to schedule a demonstration at our booth #2800.

We also invite you to join the Philips Lunch Symposium on Sunday, 1 May, to hear prominent speakers discuss the future of innovation and therapy guidance, a clinical perspective on expanding the role of MRI, and combining genomics and radiotherapy planning.

Seats are limited, so reserve yours early!

Highlights of innovations at ESTRO 2016

Pinnacle³ Auto-Planning

There are many challenges today in IMRT and VMAT Planning. It is often a labor-intensive process that generates inconsistent results. The many steps in IMRT treatment planning often end up delaying start of treatment. The planning process is tedious and repetitive, requiring significant planner/physician interaction. The quality of the resulting plans varies with the experience level of the user, creating inconsistencies in treatment. Pinnacle³ Auto-Planning makes the treatment planning process faster, less labor intensive and more reproducible. Read a case study about using Auto-Planning in an earlier edition of HotSpot.
Please view our customer testimonial video on Auto-Planning.

Pinnacle³ Proton Planning with IMPT

Determining which treatment modality is best for your patient can be difficult if you can’t compare and contrast the different treatment protocols. Pinnacle³ Proton Planning fully integrates proton therapy treatment planning with the conventional external beam treatment planning process in Pinnacle³, allowing seamless planning from a wide range of clinical applications for multiple delivery devices. Simplify treatment planning, compare treatment plans and modalities, and even plan composite treatments while enjoying an improved workflow. Pinnacle³ IMPT will be available with Pinnacle³ 16. It is currently a work in progress and is not available for sale in US and Canada.
A preview of the new Pinnacle³ 16 interface – not available for sale.

iPatient platform for Brilliance CT Big Bore

Philips is introducing the iPatient platform and a new version of Tumor LOC to the Brilliance CT Big Bore. iPatient is an advanced platform that facilitates patient-centered imaging, now and in the future. The new version of Tumor LOC is enhanced with a new user interface and patient-marking workflow that combines tools for patient marking and CT simulation to increase productivity. Powered by Pinnacle³, this version of Tumor LOC is the first step in workflow integration between the Brilliance Big Bore CT scanner and Pinnacle³ treatment planning system.
Confidence and consistency with iPatient for the Brilliance CT Big Bore.

MR-only simulation for Prostate on the next generation Ingenia MR-RT

Today, MR has even more to offer in radiation treatment planning. Available as a plug-in extension to Ingenia MR-RT, MR-only simulation allows you to adopt a single-modality imaging approach that provides excellent soft-tissue contrast you trust for target delineation – plus density information for dose calculations. Fast scanning protocols and embedded post-processing steps generate MRCAT (MR for Calculating ATtenuation) images on the MR console in just a few minutes, with the density information you’d expect from CT.
Please view our customer testimonial on MR-only Simulation. Read more about this innovation in an earlier edition of HotSpot.

What to look forward to at the symposium

Challenging conventional practices in treatment planning

Professor Lorenzo Livi, MD, PhD

Director of Radiation Oncology Unit

University of Florence, Italy

Professor Livi is the head of radiotherapy at the University of Florence. They are currently investigating the role of Pinnacle³ Auto-Planning in their clinic to see how it performs and fits into their current workflow. Professor Livi’s talk will focus on the outcome of the study and the experience of their staff in seeing whether this type of automation can indeed change their current way of working.

A clinical perspective on the expanding role of MRI

Professor Marco van Vulpen, MD, PhD

Chair of the department of Radiation Oncology

UMC Utrecht, The Netherlands

Professor Marco van Vulpen, MD, PhD is the chair of the department of Radiation Oncology of UMC Utrecht, and professor at MD Anderson Cancer Center, Houston, Texas USA. In the Centre of Image Guided Oncological Interventions at UMC Utrecht, MRI plays a central role in patient care, as well as in research projects. Professor van Vulpen will share his vision on how MRI will change radiation oncology clinical practices.

Enabling comprehensive oncology solution with genomics and radiotherapy planning

Nevenka Dimitrova, PhD

CTO Genomics

Philips Healthcare IT

Dr Dimitrova is the Chief Technology Officer within the Genomics group at Philips. She will explain Philips’ involvement in this rapidly evolving field and share her perspectives on how these early solutions will play an increasingly bigger role in the management of cancer.

For more information


For more information about the innovations shown at ESTRO 2016 and about our lunch symposium, please visit

Written by:

Joop van den Heuvel
Director Field Marketing Oncology

Share this article

Related articles

ESTRO 2015

Cancer treatments are getting increasingly sophisticated and personalized, to provide the best results for your patients.

Innovations – Integrated proton planning software

Proton therapy is a promising new treatment in radiation oncology, using a beam of protons to irradiate cancer or other diseased tissue.

MR-only simulation for prostate RT planning

With its excellent soft-tissue contrast and functional imaging capabilities, MRI has the potential to...